Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects

Hepatocellular carcinoma (HCC) is a highly aggressive liver malignancy and one of the most lethal cancers globally, with limited effective therapeutic options. Bile acids (BAs), as primary metabolites of hepatic cholesterol, undergo enterohepatic circulation involving secretion into the intestine an...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Xuemei Zhang, Lei Shi, Xiaona Lu, Wenlan Zheng, Jia Shi, Shihan Yu, Hai Feng, Zhuo Yu
Format:	Article
Language:	English
Published:	MDPI AG 2024-08-01
Subjects:	bile acids hepatocellular carcinoma gut microbiota inflammation tumor immunity
Online Access:	https://www.mdpi.com/1424-8247/17/9/1142

Similar Items

Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
by: Yang Song, et al.
Published: (2024-02-01)

Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment
by: Jin-kun Xia, et al.
Published: (2022-10-01)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
by: Yu-Lin Zhang, et al.
Published: (2022-09-01)

The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
by: Charlotte Lefort, et al.
Published: (2021-02-01)

Micro-hepatocellular carcinoma with bile duct tumor thrombus mimicking intrahepatic intraductal papillary neoplasm of the bile duct: a case report
by: Takatsugu Matsumoto, et al.
Published: (2023-04-01)

Effect of bile duct resection on the prognosis of patients with hepatocellular carcinoma combined with extrahepatic bile duct tumor thrombus
by: Xi Yu, et al.
Published: (2024-08-01)

Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
by: Meilin Wei, et al.
Published: (2024-06-01)

Interplay between bile acids, gut microbiota, and the tumor immune microenvironment: mechanistic insights and therapeutic strategies
by: Yan Tong, et al.
Published: (2025-08-01)

Taxonomic identification of bile salt hydrolase‐encoding lactobacilli: Modulation of the enterohepatic bile acid profile
by: Ziwei Song, et al.
Published: (2023-08-01)

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
by: Linsen Shi, et al.
Published: (2023-07-01)

Hepatocellular carcinoma recurrence in the extrahepatic bile duct wall: A case report
by: Taku Matsumoto, et al.
Published: (2021-03-01)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
by: Zhonglin Li, et al.
Published: (2023-08-01)

Dietary bile acids supplementation decreases hepatic fat deposition with the involvement of altered gut microbiota and liver bile acids profile in broiler chickens
by: Minghui Wang, et al.
Published: (2024-08-01)

Calycosin improves atherosclerosis by reshaping the interaction between the gut microbiome and bile acid metabolism
by: Jiaqi Fu, et al.
Published: (2025-04-01)

Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically
by: Junli Ma, et al.
Published: (2020-09-01)

Proton beam therapy for hepatocellular carcinoma with bile duct invasion
by: Takashi Iizumi, et al.
Published: (2023-08-01)

The role of bile acids in human aging
by: Jin Lihua, et al.
Published: (2024-04-01)

The role of bile acid metabolism-related genes in prognosis assessment of hepatocellular carcinoma and identification of NPC1 as a biomarker
by: Maosen Xu, et al.
Published: (2025-05-01)

Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome
by: Lixing Feng, et al.
Published: (2021-12-01)

Bile Duct Patency Maintained after Intraductal Radiofrequency Ablation in a Case of Hepatocellular Cholangiocarcinoma with Bile Duct Invasion
by: Sung Yong Han, et al.
Published: (2018-03-01)

New Kids on the Block: Bile Salt Conjugates of Microbial Origin
by: Ümran Ay, et al.
Published: (2022-02-01)

The regulatory role of bile acid microbiota in the progression of liver cirrhosis
by: Feng Zhu, et al.
Published: (2023-06-01)

Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
by: Mélanie Bourgin, et al.
Published: (2021-05-01)

Molecular mechanisms of photoperiod regulation of bile acid metabolism in Taihe silky fowls based on the gut-liver axis
by: Haiyan Zhu, et al.
Published: (2025-09-01)

Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota
by: Carlos J. Garcia, et al.
Published: (2022-05-01)

The regulatory effects of bioactive polysaccharides on intestinal function and bile acids: chemical structures, bioactivities, and mechanisms
by: Anqi Wang, et al.
Published: (2024-11-01)

Role of NLRP3 in the metabolism of bile acids and gut microbiota in CCl4-induced liver fibrosis
by: Shu Feng, et al.
Published: (2025-09-01)

Gut microbiota–regulated bile acids metabolism features in the aging process in mice
by: Kechun CHEN, et al.
Published: (2022-03-01)

Regulation of host immune function by gut microbiota-derived secondary bile acids
by: YUE Lingling, WANG Zihui, LI Xiaoqin, LI Lifeng, ZHANG Wancun, YU Zhidan
Published: (2024-06-01)

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma
by: Jun-Yi Wu, et al.
Published: (2021-03-01)

Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy
by: Haochen Yao, et al.
Published: (2024-11-01)

Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis
by: Bo Shen, et al.
Published: (2022-12-01)

Bile Acid Physiology
by: Agostino Di Ciaula, et al.
Published: (2017-11-01)

Engineered FGF19ΔKLB protects against intrahepatic cholestatic liver injury in ANIT-induced and Mdr2-/- mice model
by: Lu Shi, et al.
Published: (2023-10-01)

Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients
by: Stephanie Flynn, et al.
Published: (2020-11-01)

Better detoxifying effect of ripe forsythiae fructus over green forsythiae fructus and the potential mechanisms involving bile acids metabolism and gut microbiota
by: Tao Wang, et al.
Published: (2022-08-01)

Portal bile acid composition and microbiota along the murine intestinal tract exhibit sex differences in physiology
by: François Reichardt, et al.
Published: (2025-12-01)

Effects of Prevotella copri on insulin, gut microbiota and bile acids
by: Jiatai Gong, et al.
Published: (2024-12-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions
by: Valentina Cossiga, et al.
Published: (2023-06-01)